In Brief: Boehringer v. Johnson & Johnson
This article was originally published in The Tan Sheet
Executive Summary
Boehringer v. Johnson & Johnson: Firms settle industrial espionage litigation filed last June in which Boehringer Mannheim claimed that J&J's LifeScan division illegally obtained information relating to its Accutrend DM blood glucose monitor sold in the U.S. under the trade name Accu-chek Instant DM ("The Tan Sheet" June 24, 1996, p. 4). Counterclaims filed by LifeScan in September also are resolved under the settlement. Terms were not disclosed...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning